关键信息
-
基因名
NR1H4
- 应用
-
别名
Farnesoid X-activated receptorFarnesol receptor HRR-1Nuclear receptor subfamily 1 group H member 4Retinoid X receptor-interacting protein 14 ;RXR-interacting protein 14
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96RI1
-
表达区间
1-476aa
-
分子量
70.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
NR1H4, also known as Liver X Receptor alpha (LXRα), is a nuclear receptor that plays a pivotal role in lipid metabolism, cholesterol homeostasis, and inflammatory responses. It is activated by oxysterols, which are cholesterol derivatives, and functions as a key regulator of genes involved in lipid synthesis, uptake, and efflux. Research into NR1H4 has gained significant attention due to its implications in various metabolic disorders, including dyslipidemia, atherosclerosis, and non-alcoholic fatty liver disease (NAFLD). Understanding the mechanisms by which NR1H4 regulates cholesterol metabolism can aid in the development of therapeutic strategies for these conditions. Moreover, LXRα is also implicated in neuroprotection and the modulation of immune responses, revealing its potential as a target for treatments beyond metabolic diseases. The study of NR1H4 recombinant proteins allows for the elucidation of its structure-function relationships, enabling the exploration of novel ligands and modulators that could enhance its therapeutic potential. Overall, the investigation of NR1H4 recombinant proteins holds promise for advancing our knowledge of metabolic regulation and developing innovative approaches for the treatment of related disorders.
